Castration-resistant prostate cancer: [177Lu]Lu-PSMA-617 versus cabazitaxel Comment

被引：0
|
作者：
Todenhoefer, Tilman [1 ]
机构：
[1] Studienpraxis Urol, Steinengrabenstr 17, D-72622 Nurtingen, Germany
来源：
AKTUELLE UROLOGIE | 2023年 / 54卷 / 04期
关键词：
D O I：
10.1055/a-2084-8214
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu- PSMA-617
    Muniz, Miguel
    Sartor, Oliver
    Orme, Jacob J.
    Koch, Regina M.
    Rosenow, Hana R.
    Mahmoud, Ahmed M.
    Andrews, Jack R.
    Kase, Adam M.
    Riaz, Irbaz B.
    Bilgin, Gokce Belge
    Thorpe, Matthew P.
    Kendi, A. Tuba
    Johnson, Geoffrey B.
    Ravi, Praful
    Kwon, Eugene D.
    Childs, Daniel S.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1932 - 1938
  • [42] Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radioligand Therapy
    Gaal, Sebastian
    Huang, Kai
    Rogasch, Julian M. M.
    Jochens, Hans V.
    De Santis, Maria
    Erber, Barbara
    Amthauer, Holger
    CANCERS, 2023, 15 (20)
  • [43] Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results.
    Herrmann, Ken
    Gafita, Andrei
    De Bono, Johann S.
    Sartor, A. Oliver
    Chi, Kim N.
    Krause, Bernd J.
    Rahbar, Kambiz
    Tagawa, Scott T.
    Czernin, Johannes
    El-Haddad, Ghassan
    Wong, Connie
    Zhang, Zhaojie
    Wilke, Celine
    Mirante, Osvaldo
    Morris, Michael J.
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 208 - 208
  • [44] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [45] Review of 177Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Sun, Michael
    Niaz, Muhammad O.
    Nelson, Adlai
    Skafida, Myrto
    Niaz, Muhammad J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [46] Real-life data on [177Lu]Lu-PSMA-617: Descriptive analysis on the largest metastatic castration-resistant prostate cancer (mCRPC) cohort treated in France.
    Roubaud, Guilhem
    Somme, Francois
    Barthelemy, Philippe
    Olivier, Pierre
    Massard, Vincent
    Giraudet, Anne Laure
    Flechon, Aude
    Girault, Sylvie
    Abadie Lacourtoisie, Sophie
    Bailly, Clement
    Viala, Caroline
    Godbert, Yann
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 129 - 129
  • [47] [177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial
    Satapathy, Swayamjeet
    Mittal, Bhagwant Rai
    Sood, Ashwani
    Das, Chandan Krushna
    Mavuduru, Ravimohan Suryanarayan
    Goyal, Shikha
    Shukla, Jaya
    Singh, Shrawan Kumar
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1726 - 1729
  • [48] Tumour dosimetry across 6 cycles of [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: results from the VISION sub-study
    Herrmann, K.
    Krause, B.
    Chi, K.
    Sartor, O.
    Fizazi, K.
    Morris, M. J.
    De Bono, J.
    Tagawa, S.
    Kurth, J.
    Eiber, M.
    Lassmann, M.
    Jentzen, W.
    Sparks, R.
    Nguyen, Q.
    Blumentstein, L.
    Klein, P.
    Wilke, C.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S278 - S279
  • [49] Real-life data on [177Lu]Lu-PSMA-617: Descriptive analysis on the largest RLT metastatic castration-resistant prostate cancer (mCRPC) cohort treated in France
    Giraudet, A.
    Bailly, C.
    Barthelemy, P.
    Somme, F.
    Olivier, P.
    Massard, V.
    Godbert, Y.
    Roubaud, G.
    Girault, S.
    Abadie, S.
    Viala, C.
    Flechon, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S279 - S279
  • [50] Multi- cycle dosimetry of [177Lu]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study
    Kurth, J.
    Rahbar, K.
    Eiber, M.
    Sparks, R.
    Baca, N.
    Krause, B. J.
    Lassmann, M.
    Jentzen, W.
    Chicco, D.
    Klein, P.
    Blumenstein, L.
    Basque, J.
    Herrmann, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S129 - S129
12345